Literature DB >> 2149655

Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.

M Albus1, W Maier, D Shera, P Bech.   

Abstract

The Marks-Sheehan anxiety scales are the only scales where self-ratings and observer ratings are perfectly matched by the number, the content and the scaling of the items. Therefore these scales are an excellent tool to investigate the compatibility and to study different structures in self- and observer ratings. This was done by using the data material on the Marks-Sheehan scales of the Cross National Collaborative Panic Study. In this study 1168 outpatients who met the DSM-III criteria for panic disorder were randomly allocated either to alprazolam, imipramine or placebo treatment. Our results show that the Marks-Sheehan scales are highly comparable to other established rating scales. Both scales have a similar stable and consistent factor pattern for somatic symptoms but not for psychic symptoms of anxiety. Our results provide empirical evidence that the low consistencies between self- and observer ratings reported so far can be improved by using a rating scale which matches up item for self- and observer ratings. However, other sources of disagreement can only be solved by more elaborated item descriptions and training of patients as well as raters to obtain a better compatibility between self- and observer rating scales.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2149655     DOI: 10.1007/bf02189978

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  14 in total

Review 1.  Outcome criteria in antidepressant drug trials: self-rating versus observer-rating scales.

Authors:  H J Möller
Journal:  Pharmacopsychiatry       Date:  1991-05       Impact factor: 5.788

2.  Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.

Authors:  W Maier; M Albus; R Buller; D Nutzinger; D Shera; P Bech
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1990       Impact factor: 5.270

3.  The problem of diagnosis in psychiatric research.

Authors:  P Williams
Journal:  J R Soc Med       Date:  1986-01       Impact factor: 5.344

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

5.  Brief standard self-rating for phobic patients.

Authors:  I M Marks; A M Mathews
Journal:  Behav Res Ther       Date:  1979

Review 6.  Quality of life in psychosomatic research. A psychometric model.

Authors:  P Bech
Journal:  Psychopathology       Date:  1987       Impact factor: 1.944

7.  Revised diagnostic criteria and a new structured interview for diagnosing anxiety disorders.

Authors:  R L Spitzer; J B Williams
Journal:  J Psychiatr Res       Date:  1988       Impact factor: 4.791

8.  Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

Authors:  R J Kahn; D M McNair; R S Lipman; L Covi; K Rickels; R Downing; S Fisher; L M Frankenthaler
Journal:  Arch Gen Psychiatry       Date:  1986-01

9.  Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.

Authors:  J C Ballenger; G D Burrows; R L DuPont; I M Lesser; R Noyes; J C Pecknold; A Rifkin; R P Swinson
Journal:  Arch Gen Psychiatry       Date:  1988-05

10.  Rating scales for depression and anxiety: a current perspective.

Authors:  R P Snaith; C M Taylor
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

View more
  3 in total

1.  Self- and observer assessment in anxiolytic drug trials: a comparison of their validity.

Authors:  W Maier; M Albus; R Buller; D Nutzinger; D Shera; P Bech
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1990       Impact factor: 5.270

Review 2.  Antidepressants versus placebo for panic disorder in adults.

Authors:  Irene Bighelli; Mariasole Castellazzi; Andrea Cipriani; Francesca Girlanda; Giuseppe Guaiana; Markus Koesters; Giulia Turrini; Toshi A Furukawa; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2018-04-05

3.  Quality of life in borderline patients comorbid with anxiety spectrum disorders - a cross-sectional study.

Authors:  Ales Grambal; Jan Prasko; Dana Kamaradova; Klara Latalova; Michaela Holubova; Zuzana Sedláčková; Radovan Hruby
Journal:  Patient Prefer Adherence       Date:  2016-08-01       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.